303
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Uveitis in Sarcoidosis – Clinical Features and Comparison with Other Non-infectious Uveitis

, BHB, MBChB, PhDORCID Icon, , MPh, MSc, PhD, , MD, PhD & , PhD, FRCOphth
Pages 367-373 | Received 04 Feb 2020, Accepted 15 Nov 2021, Published online: 24 Feb 2022

References

  • Jones N, Mochizuki M. Sarcoidosis: epidemiology and clinical features. Ocul Immunol Inflamm. 2010;18:72–79.
  • Nowinski TS. Ocular manifestations of sarcoidosis. Curr Opin Ophthalmol. 1998;9(6):80–84. doi:10.1097/00055735-199812000-00014.
  • Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–2165. doi:10.1056/NEJMra071714.
  • Rizatto G. Extrapulmonary presentation of sarcoidosis. Curr Opin Pulmon Med. 2001;7:295–297. doi:10.1097/00063198-200109000-00008.
  • Jamilloux Y, Kodjikian L, Broussolle C, et al. Sarcoidosis and uveitis. Autoimmun Rev. 2014;13(8):840–849.
  • Kawaguchi T, Hanada A, Horie S, et al. Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients. Jpn J Ophthalmol. 2007;51(2):121–126. doi:10.1007/s10384-006-0413-2.
  • Herbort CP, Rao NA, Mochizuki M; members of Scientific Committee of First International Workshop on Ocular S. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–169. doi:10.1080/09273940902818861.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516.
  • Birnbaum AD, Oh FS, Chakrabarti A, Tessler HH, Goldstein DA. Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis. Arch Ophthalmol. 2011;129(4):409–413. doi:10.1001/archophthalmol.2011.52.
  • Tomkins-Netzer O, Talat L, Bar A, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. 2014;121(12):2387–2392. doi:10.1016/j.ophtha.2014.07.007.
  • Hosoya S, Kataoka M, Nakata Y, et al. Clinical features of 125 patients with sarcoidosis: okayama University Hospital review of a recent 10-year period. Acta Med Okayama. 1992;46(1):31–36.
  • Power WJ, Neves RA, Rodriguez A, et al. The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology. 1995;102(12):2007–2011. doi:10.1016/S0161-6420(95)30763-4.
  • Niederer RL, Al-Janabi A, Lightman SL, Tomkins-Netzer O. Serum angiotensin-converting enzyme has a high negative predictive value in the investigation for systemic sarcoidosis. Am J Ophthalmol. 2018;194:82–87. doi:10.1016/j.ajo.2018.07.010.
  • Niederer RL, Sims JL. Utility of screening investigations for systemic sarcoidosis in undifferentiated uveitis. Am J Ophthalmol. 2019;206:149–153. doi:10.1016/j.ajo.2019.04.012.
  • Jabs DA, Busingye J. Approach to the diagnosis of the uveitides. Am J Ophthalmol. 2013;156(2):228–236. doi:10.1016/j.ajo.2013.03.027.
  • Kaiser PK, Lowder CY, Sullivan P, et al. Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol. 2002;133(4):499–505. doi:10.1016/S0002-9394(02)01333-8.
  • Smith-Bindman R. Is computed tomography safe? N Engl J Med. 2010;363(1):1–4. doi:10.1056/NEJMp1002530.
  • Takase H, Shimizu K, Yamada Y, Hanada A, Takahashi H, Mochizuki M. Validation of international criteria for the diagnosis of ocular sarcoidosis proposed by the first international workshop on ocular sarcoidosis. Jpn J Ophthalmol. 2010;54(6):529–536. doi:10.1007/s10384-010-0873-2.
  • Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, and Rao NA. International workshop on ocular sarcoidosis study group. Revised criteria of International Workshopon Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10): 1418–1422. [Epub ahead of press].
  • Iwata K, Nanba K, Sobue K, Abe H. Ocular sarcoidosis: evaluation of intraocular findings. Ann N Y Acad Sci. 1976;276:445–454. doi:10.1111/j.1749-6632.1976.tb47057.x.
  • Acharya NR, Browne EN, Rao N, Mochizuki M; International Ocular Sarcoidosis Working Group. Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients. Ophthalmology. 2018;125(1):119–126. doi:10.1016/j.ophtha.2017.07.006.
  • Niederer RL, Ma SP, Wilsher ML, et al. Systemic associations of sarcoid uveitis: correlation with uveitis phenotype and ethnicity. Am J Ophthalmol. 2021;229:169–175. doi:10.1016/j.ajo.2021.03.003.
  • Desai UR, Tawansy KA, Joondeph BC, Schiffman RM. Choroidal granulomas in systemic sarcoidosis. Retina. 2001;21(1):40–47. doi:10.1097/00006982-200102000-00007.
  • Laties AM, Scheie HG. Sarcoid granuloma of the optic disk: evolution of multiple small tumors. Trans Am Ophthalmol Soc. 1970;68:219–233.
  • Lobo A, Barton K, Minassian D, et al. Visual loss in sarcoid-related uveitis. Clin Exp Ophthalmol. 2003;31(4):310–316. doi:10.1046/j.1442-9071.2003.00666.x.
  • Sungur G, Hazirolan D, Bilgin G. Pattern of ocular findings in patients with biopsy-proven sarcoidosis in Turkey. Ocul Immunol Inflamm. 2013;21(6):455–461. doi:10.3109/09273948.2013.775311.
  • Merayo-Lloves J, Power WJ, Rodriguez A, et al. Secondary glaucoma in patients with uveitis. Ophthalmologica. 1999;213(5):300–304. doi:10.1159/000027443.
  • Takahashi T, Ohtani S, Miyata K, et al. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol. 2002;46(5):556–562. doi:10.1016/S0021-5155(02)00549-X.
  • Grutters JC, van den Bosch JMM, van den Bosch JMM. Corticosteroid treatment in sarcoidosis. Eur Resp J. 2006;28(3):627–636. doi:10.1183/09031936.06.00105805.
  • Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol. 2000;84(1):100–116. doi:10.1136/bjo.84.1.110.
  • Dana MR, Merayo-Lloves J, Schaumberg DA, et al. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmol. 1996;103:1846–1853. doi:10.1016/S0161-6420(96)30417-X.
  • Lee SY, Lee HG, Kim DS, et al. Ocular sarcoidosis in a Korean population. J Korean Med Sci. 2009;24(3):413–419. doi:10.3346/jkms.2009.24.3.413.
  • Rochepeau C, Jamilloux Y, Kerevere S, et al. Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis. Br J Ophthalmol. 2017;101(7):656–861. doi:10.1136/bjophthalmol-2016-309767.
  • Ma S, Rogers SL, Hall AJ, et al. Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis. Am J Ophthalmol. 2019;198:30–36. doi:10.1016/j.ajo.2018.09.013.
  • Niederer RL, Talat L, Bar A, et al. Predictors of long term visual outcome in intermediate uveitis. Ophthalmol. 2017;124(3):393–398. doi:10.1016/j.ophtha.2016.11.013.
  • Jones NP, Tsierkezou L, Patton N. Lymphopenia as a predictor of sarcoidosis in patients with uveitis. Br J Ophthalmol. 2016;100(10):1393–1396. doi:10.1136/bjophthalmol-2015-307455.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.